Intracavitary bleomycin vs interferon in the management of malignant pleural effusions
- PMID: 9554669
- DOI: 10.1378/chest.113.4.1145
Intracavitary bleomycin vs interferon in the management of malignant pleural effusions
Comment on
-
Recombinant interferon alpha-2b in the management of malignant pleural effusions.Chest. 1997 Jun;111(6):1597-9. doi: 10.1378/chest.111.6.1597. Chest. 1997. PMID: 9187180 Clinical Trial.
Similar articles
-
[Current treatment strategy in malignant pleural effusion].Wien Klin Wochenschr. 1996;108(9):255-61. Wien Klin Wochenschr. 1996. PMID: 8686317 Review. German.
-
On the management of malignant pleural effusions.Chest. 1994 Jan;105(1):1-2. doi: 10.1378/chest.105.1.1a. Chest. 1994. PMID: 7506134 No abstract available.
-
Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study.J Surg Oncol. 1987 Oct;36(2):81-3. doi: 10.1002/jso.2930360202. J Surg Oncol. 1987. PMID: 2443762 Clinical Trial.
-
Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion.Jpn J Clin Oncol. 1998 Mar;28(3):187-91. doi: 10.1093/jjco/28.3.187. Jpn J Clin Oncol. 1998. PMID: 9614441
-
Bleomycin and tetracycline in malignant pleural effusions: a review.Semin Oncol. 1992 Apr;19(2 Suppl 5):59-62; discussion 62-3. Semin Oncol. 1992. PMID: 1384146 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources